Carvedilol ER 20 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQT9L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,168
Award facts
- Contract value 100% obligated
- $10,167.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 8, 2026, for the supply of Carvedilol ER 20 mg capsules (30-count units) valued at $10,167.84, with completion scheduled for January 9, 2026. This non-set-aside award was competitively bid and represents a task order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the location of performance for this order—serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through this comprehensive vehicle.
The delivery order falls within the scope of DLA's pharmaceutical supply chain operations, which provide essential medications to military treatment facilities and veteran healthcare programs globally. Carvedilol ER is a cardiovascular medication commonly used in federal healthcare systems, and this order exemplifies the routine, competitive pharmaceutical procurement conducted through AmerisourceBergen's prime vendor agreement with DLA. The company's established portfolio with DLA demonstrates its capability to efficiently fulfill government requirements across diverse therapeutic domains while maintaining firm fixed pricing structures for cost predictability.
Quick answers
Who was awarded contract SPE2DR26FQT9L?
SPE2DR26FQT9L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FQT9L worth?
The government has obligated $10,168 on SPE2DR26FQT9L.
Is contract SPE2DR26FQT9L an order under another contract?
Yes. SPE2DR26FQT9L is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT9L competed?
The extent of competition for SPE2DR26FQT9L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award